A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients with Multiple Myeloma

OBJECTIVE: Multiple myeloma (MM) is the second most common hematological cancer. An attempt to treat MM using a topoisomerase I inhibitor was made based on our previous non-clinical studies suggesting the usefulness of an SN-38 derivative. Our aim was to conduct a phase I/II study of NK012, a micell...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Intern Med
Egile Nagusiak: Ri, Masaki, Suzuki, Kenshi, Iida, Shinsuke, Hatake, Kiyohiko, Chou, Takaaki, Taniwaki, Masafumi, Watanabe, Noriko, Tsukamoto, Tetsuji
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Japanese Society of Internal Medicine 2017
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5919849/
https://ncbi.nlm.nih.gov/pubmed/29225263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.9567-17
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak